KAREN BURNETT: Open Payments
NPI 1639254386 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 95 payments from 24 companies in 2025. Trend: 2023 $1,360 · 2024 $1,369 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $247 |
| Amgen Inc. | 17 | $152 |
| GlaxoSmithKline, LLC. | 8 | $144 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| PFIZER INC. | 6 | $122 |
| Lilly USA, LLC | 7 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82 |
| Astellas Pharma US Inc | 3 | $55 |
| Novo Nordisk Inc | 3 | $50 |
Products named: VRAYLAR, JARDIANCE, Kerendia, NURTEC ODT, AIRSUPRA, TRELEGY ELLIPTA, AREXVY, Veozah.
Industry payments across CO — which companies pay providers there.
